Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress

Applied Skills Session 4513

Selecting Patients for Advanced Therapies in Parkinson's Disease

Wednesday, October 7, 2026
16:00 - 17:30 | Conference Room E3, Level 3

In this session, the faculty will be able to present a case-based approach to selecting advanced therapies for Parkinson's disease patients.

Moderator(s):

Roberto Cilia, Italy

Presenters:

Philippe Salles, Chile

Antonella Macerollo, United Kingdom

CSPC Liaison(s):

Maria Stamelou, Greece

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Recognize the indications for various advanced therapies in Parkinson's disease patients
  2. Assess the criteria for patient selection for each of these methods on a case-based approach
  3. Analyze the benefits, limitations and possible synergistic benefits of advanced therapies in Parkinson's disease

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry

Education Level

Beginner / Foundational
Intermediate / Experienced